First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.227 USD -3.81% Market Closed
Updated: May 20, 2024

Sonoma Pharmaceuticals Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sonoma Pharmaceuticals Inc
Other Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Other Liabilities
$4.9m
CAGR 3-Years
89%
CAGR 5-Years
67%
CAGR 10-Years
12%
Johnson & Johnson
NYSE:JNJ
Other Liabilities
$25B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Bristol-Myers Squibb Co
NYSE:BMY
Other Liabilities
$6.7B
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
9%
Pfizer Inc
NYSE:PFE
Other Liabilities
$25.8B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Other Liabilities
$8.3B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Other Liabilities
$7.9B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
6%

See Also

What is Sonoma Pharmaceuticals Inc's Other Liabilities?
Other Liabilities
4.9m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Other Liabilities amounts to 4.9m USD.

What is Sonoma Pharmaceuticals Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
12%

Over the last year, the Other Liabilities growth was 10%. The average annual Other Liabilities growth rates for Sonoma Pharmaceuticals Inc have been 89% over the past three years , 67% over the past five years , and 12% over the past ten years .